Book FT3 Test in Pune | Free Triiodothyronine Thyroid Test

The Free Triiodothyronine test is a blood test that measures the level of FT3, the unbound and biologically active fraction of triiodothyronine, the most potent thyroid hormone produced by the body. The thyroid gland secretes two primary hormones, thyroxine (T4) and triiodothyronine (T3), with the majority of circulating T3 derived not directly from thyroid secretion but from peripheral conversion of T4 to T3 by deiodinase enzymes in tissues including the liver, kidneys, and skeletal muscle. Approximately 99.7 percent of circulating T3 is bound to carrier proteins including thyroxine-binding globulin, albumin, and transthyretin, leaving only a tiny fraction of around 0.3 percent as free, unbound, and biologically active FT3 capable of entering cells and exerting physiological effects. Measuring FT3 rather than total T3 eliminates the influence of binding protein concentrations, which can be significantly altered by pregnancy, liver disease, oral contraceptive use, and various medications, making FT3 a more reliable and accurate reflection of true thyroid hormone activity at the cellular level. FT3 is the metabolically active form that directly regulates gene transcription, basal metabolic rate, cardiac function, thermoregulation, gastrointestinal motility, bone turnover, and neurological development and function throughout the body. In India, thyroid disorders are among the most prevalent endocrine conditions, affecting an estimated 42 million people, with hypothyroidism and hyperthyroidism both carrying significant morbidity when undiagnosed or inadequately managed. FT3 measurement provides essential information about the severity and type of thyroid dysfunction that TSH and FT4 alone cannot fully characterise. The test is performed on a small blood sample drawn from a vein and completed in under five minutes.

Doctors prescribe an FT3 test in the following situations: Diagnosing hyperthyroidism and distinguishing its severity where elevated FT3 alongside suppressed TSH confirms active thyroid hormone excess, and in T3 toxicosis, a condition where FT3 is disproportionately elevated while FT4 remains normal, measurement of FT3 is the only way to identify and correctly diagnose this specific hyperthyroid variant. Evaluating suspected hypothyroidism in patients with fatigue, weight gain, cold intolerance, constipation, and depression where FT3 measurement alongside TSH and FT4 provides a complete picture of thyroid hormone availability, particularly in patients with normal FT4 but persistent symptoms where low FT3 from impaired peripheral conversion may explain the clinical presentation. Monitoring thyroid hormone replacement therapy in patients on levothyroxine where FT3 assessment helps identify patients with inadequate peripheral T4 to T3 conversion who may benefit from combination therapy with both T4 and T3, or dose optimisation to achieve symptomatic relief alongside biochemical normalisation. Assessing non-thyroidal illness syndrome, also known as sick euthyroid syndrome, in critically ill patients where FT3 falls dramatically due to reduced peripheral conversion of T4 to T3 during severe systemic illness, surgery, or starvation, and where accurate interpretation prevents inappropriate thyroid hormone treatment in a non-thyroidal condition. Investigating Graves' disease and toxic multinodular goitre where FT3 is frequently disproportionately elevated relative to FT4 due to preferential T3 secretion by hyperfunctioning thyroid tissue, and where FT3 normalisation is a key treatment target guiding dose adjustments of antithyroid medications. Evaluating thyroid function in pregnancy where altered binding protein levels make total T3 unreliable, and FT3 alongside FT4 and TSH provides the most accurate assessment of maternal thyroid status critical for foetal neurological development during the first trimester.

The FT3 test measures the concentration of unbound free triiodothyronine in the blood, expressed in picograms per millilitre (pg/mL) or picomoles per litre (pmol/L). The normal reference range for adults is 2.0 to 4.4 pg/mL (3.1 to 6.8 pmol/L), with no clinically significant variation by gender and only modest age-related changes. Normal (2.0 to 4.4 pg/mL) A result within the normal range indicates that free triiodothyronine availability is within the expected physiological range for normal metabolic function. In patients on thyroid hormone replacement therapy, a normal FT3 alongside normal TSH and FT4 suggests adequate and well-balanced thyroid hormone status, though symptom correlation remains essential for complete clinical assessment. Low FT3 (Below 2.0 pg/mL) A low FT3 result indicates reduced availability of the most biologically active thyroid hormone at the cellular level. This may reflect primary hypothyroidism, secondary hypothyroidism from pituitary dysfunction, impaired peripheral T4 to T3 conversion due to selenium deficiency, chronic illness, or medications, or non-thyroidal illness syndrome in acutely unwell patients where low FT3 is an adaptive rather than pathological response requiring clinical context for accurate interpretation. Elevated FT3 (Above 4.4 pg/mL) An elevated FT3 result indicates excess thyroid hormone activity and is most commonly associated with hyperthyroidism from Graves' disease, toxic multinodular goitre, or toxic adenoma. Isolated FT3 elevation with normal FT4 and suppressed TSH is diagnostic of T3 toxicosis and requires antithyroid treatment. Elevated FT3 in the context of exogenous thyroid hormone excess indicates over-treatment requiring dose reduction under medical supervision.

No fasting is strictly required for the FT3 test, as food intake does not significantly affect free thyroid hormone concentrations. However, since FT3 is routinely ordered alongside TSH, FT4, and other metabolic parameters, morning fasting collection is generally preferred to standardise conditions across the full panel and to ensure consistency with recommended TSH sampling timing. Inform your doctor about all thyroid-related and other medications currently being taken before the test, particularly levothyroxine, liothyronine, antithyroid drugs including methimazole and carbimazole, amiodarone, corticosteroids, beta-blockers, and lithium, as these directly alter thyroid hormone levels, peripheral conversion of T4 to T3, and the binding protein environment, all of which influence FT3 results. Biotin supplementation at high doses is known to interfere with immunoassay-based thyroid hormone tests including FT3 and can produce falsely elevated or falsely low results depending on the assay platform used. Biotin supplements should be stopped at least 48 to 72 hours before testing and this should be disclosed to your healthcare provider. If you are undergoing serial FT3 measurements to monitor treatment response, consistent morning sampling and use of the same laboratory assay platform ensures reliable trend comparison across visits. Staying well hydrated before the blood draw facilitates easier venous access and a smooth collection experience.

If you are booking through the SecondMedic platform the FT3 test price in Pune can cost you around Rs. 290. You may also consider booking a comprehensive thyroid panel that includes FT3 alongside TSH, FT4, and Anti-TPO antibodies for a complete assessment of thyroid function and autoimmune status at a bundled price on SecondMedic.

SecondMedic offers convenient home sample collection for the FT3 test in Pune, making it easy to get tested without visiting a diagnostic centre. Home collection is available free of charge for orders above Rs. 300. A trained phlebotomist will visit your preferred address between 7 AM and 10 PM, seven days a week, including Sundays and public holidays. Your blood sample is processed at NABL-accredited partner laboratories, and your report is delivered within 24 hours directly to your WhatsApp and email.